Natalie Castellana is CEO of Digital Proteomics, where she focuses on developing disruptive technologies for antibody discovery and characterization. Prior to joining Digital Proteomics, Dr. Castellana focused on developing novel proteogenomic methods for genome annotation and antibody proteomic sequencing. She received her PhD in Computer Science from the University of California - San Diego in 2012.